Maysaa Abdulla
Uppsala, C 75185, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Outcome in PCNSL patients and its association with PD-L1+ leukocytes in the tumor microenvironment.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 27, 2022
Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology.
Journal: Genes, chromosomes & cancer
Published: August 10, 2021
PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
Journal: Acta oncologica (Stockholm, Sweden)
Published: February 13, 2021
Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome.
Journal: American journal of hematology
Published: May 20, 2020
Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma.
Journal: European journal of haematology
Published: October 09, 2019
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.
Journal: American journal of hematology
Published: July 25, 2019
Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research.
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 01, 2016
A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 24, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026